Glaucoma treatment in Israel

Prof. Michael Waisbourd, an ophthalmologist and glaucoma specialist, is an attending physician and director of the Glaucoma Research Center at Tel-Aviv Medical Center, Israel (Sourasky-Ichilov).

Education: Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel

Membership in professional organizations:

• American Academy of Ophthalmology;
• Association for Research in Vision and Ophthalmology;
• American Glaucoma Society;
• Israeli Ophthalmology Society;
• Israeli Medical Association.

Professor Anat Levenshtein is an expert in retinal surgery, ultrasound ophthalmic treatment, intraocular injections, epiretinal membrane peeling and cataract surgery.

Specialization:

• age-related retinal degeneration (cataract, glaucoma), especially early detection;
• inflammatory diseases of the eye;
• diabetic retinopathy and retinal vein obstruction;
• macular hole and retinal breaks;
• ERM membrane;
• PVD;
• CSR.

Professor Loewenstein has published more than 280 scientific articles in the world’s leading scientific journals, and is the author of more than 25 book chapters.

Membership in professional organizations:

• Member of the Board of Directors of the EURETINA Association;
• International Macula Society (since 2012 International Representative on the Executive Board of the Macula Society);
• Israeli Medical Association;
• Israeli Ophthalmological Society;
• Israeli Research Society;
• Israeli Retinal Society;
• Association for Research in Vision and Ophthalmology;
• American Academy of Ophthalmology (AAO);
• American Retinal Society (ASRS);
• Vitreous Body Society;
• Association for the Practice of Clinical Research;
• Jules Gonin Club;
• National Board of Surgery, Anesthesia and Critical Care;
• European Society of Ophthalmology (SOE representative in Israel).

Professor Eitan Blumenthal is a recognized specialist in the field of surgical interventions for complex cases of glaucoma and cataracts. Professor Blumenthal is the author of numerous scientific publications in specialized medical journals, a participant in clinical research in the field of ophthalmology, and a lecturer at the Technion Faculty of Medicine. He developed and implemented unique methods for the diagnosis and surgical treatment of glaucoma, which are used today by ophthalmologists around the world.

Specialization: glaucoma and cataract surgery, eye injuries

Academic activities:

• 1998-2000 Lecturer at the Department of Ophthalmology, University of California School of Medicine, San Diego, USA;
• 1999-2007 Lecturer, then Senior Lecturer, Department of Ophthalmology, Hebrew University, Jerusalem;
• Since 2014 Professor, Department of Ophthalmology, Faculty of Medicine, Technion, Haifa.
• Participation in professional organizations:
• International Glaucoma Association (WGA);
• International Association for Research in Ophthalmology (ARVO);
• American Academy of Ophthalmology (AAO);
• Israeli Society for Research in Ophthalmology (ISVER);
• Israeli Ophthalmological Society (IOS);
• Israeli Medical Association (IMA).

Specialization:

• age-related macular degeneration
• vascular disease of the cell
• vitreoretinal diseases
• retinopathy due to diabetes
• retinitis pigmentosa
• cataract surgery

Education:

• 1994 – Graduated from the Medical Faculty of the Hebrew University, Jerusalem.
• He completed an internship in ophthalmology at the Hadassah Hospital and at the Maryland School of Medicine, USA.
• 2003–2006 He specialized in the treatment of ophthalmic pathologies at the Johns Hopkins Hospital, at the specialized department at the Jerusalem University Medical Clinic.

Research and publications:

• The professor was engaged in research activities in the field of molecular ophthalmology at the University. Johns Hopkins, Baltimore Medical School, USA (2003-2006)
• More than 170 scientific articles have been published in authoritative medical journals in Israel and European countries, which cover the topic of neovascular, macular, age-related degenerative processes, hereditary and other factors of visual impairment, the impact of modern therapeutic methods and medications on the course of eye diseases.